|
|
Astria Therapeutics inc (NASDAQ: ATXS) |
|
*Market share is calculated based on total revenue.
News about Astria Therapeutics inc Contracts |
March 25, 2024
Abstract:This article provides an in-depth analysis of the positive initial proof-of-concept results from the ALPHA-STAR Phase 1b/2 clinical trial evaluating STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, in hereditary angioedema (HAE) patients. The study, conducted by Astria Therapeutics, Inc., a biopharmaceutical company dedicated to developing innovative therapies for allergic and immunological diseases, has demonstrated a favorable safety and tolerability profile, along with a significant reduction in mean monthly attacks of HAE. 1. Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent episodes of localized swelling, leading to significant morbidity and poten...
|
Publicly Traded Peers of Astria Therapeutics inc
Amgen Inc
Share Performance
+19.61%
This Quarter
|
Amgen Inc
Profile
Amgen Inc.s business model focuses on leveraging advanced biotechnology to create therapeutic products for various diseases, particularly in the fields of oncology, inflammation, and cardiovascular health. The company invests heavily in research and development to drive innovation, while also utilizing strategic partnerships and acquisitions to enhance its product pipeline. Additionally, Amgen emphasizes a strong global commercial presence to maximize the accessibility and impact of its therapeutics in the healthcare market.
More about Amgen Inc 's Market Share
|
Regeneron Pharmaceuticals Inc
Share Performance
-5.59%
This Quarter
|
Regeneron Pharmaceuticals Inc
Profile
Regeneron Pharmaceuticals Inc operates a business model centered on the discovery and commercialization of cutting-edge biopharmaceuticals, particularly in the fields of ophthalmology, oncology, immunology, and rare diseases. They leverage their strong research and development capabilities, including their proprietary technologies, to create innovative therapies that address unmet medical needs. Additionally, Regeneron forms strategic collaborations and partnerships to enhance their development pipeline and expand market access for their products.
More about Regeneron Pharmaceuticals Inc 's Market Share
|
Vertex Pharmaceuticals Inc
Share Performance
+9.74%
30 Days
|
Vertex Pharmaceuticals Inc
Profile
Vertex Pharmaceuticals Incs business model centers on the research and development of innovative therapies, primarily targeting cystic fibrosis and other serious diseases. They emphasize collaboration with organizations, strategic partnerships, and robust investment in R&D to deliver transformative treatments to patients and enhance their quality of life.
More about Vertex Pharmaceuticals Inc's Market Share
|
Novartis Ag
Share Performance
+16.58%
This Quarter
|
Novartis Ag
Profile
Novartis AG's business model is centered around the development, manufacturing, and marketing of innovative pharmaceutical products.
More about Novartis Ag's Market Share
|
Gilead Sciences Inc
Share Performance
-1.65%
30 Days
|
Gilead Sciences Inc
Profile
Gilead Sciences Incs business model centers on researching, developing, and marketing innovative medicines, primarily targeting antiviral therapies. They focus on addressing unmet medical needs to enhance patient health globally.
More about Gilead Sciences Inc 's Market Share
|
Takeda Pharmaceutical Company Limited
Share Performance
+1.00%
Over The Past 5 Days
|
Takeda Pharmaceutical Company Limited
Profile
Takeda Pharmaceutical Company Limited operates under a business model that primarily focuses on research, development, and commercialization of innovative pharmaceutical products. They collaborate with various stakeholders across the healthcare industry, including academia, biotechnology companies, and patient advocacy groups, to drive scientific advancements and understand patient needs. By leveraging their expertise, global presence, and strategic partnerships, Takeda aims to make a positive impact on patients' lives while ensuring long-term growth and sustainability.
More about Takeda Pharmaceutical Company Limited's Market Share
|
Pfizer Inc
Share Performance
-0.64%
This Quarter
|
Pfizer Inc
Profile
Pfizer Inc operates as a global pharmaceutical company that focuses on researching, developing, manufacturing, and marketing innovative medicines. Its business model emphasizes significant investment in research and development to build a diverse portfolio of therapies across various therapeutic areas, while leveraging strategic alliances and collaborations to enhance commercialization and drive growth.
More about Pfizer Inc's Market Share
|
Intercept Pharmaceuticals inc
Share Performance
+82.87%
This Quarter
|
Intercept Pharmaceuticals inc
Profile
Intercept Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development and commercialization of novel therapeutics in the field of chronic liver diseases. Their business model revolves around identifying and targeting specific liver diseases with high unmet medical needs, conducting extensive research and clinical trials to develop effective therapies, and then commercializing these drugs globally to generate sustainable revenue streams. By addressing liver diseases with innovative treatments, Intercept aims to improve patient outcomes and establish a profitable position in the pharmaceutical industry.
More about Intercept Pharmaceuticals inc 's Market Share
|
Ventyx Biosciences Inc
Share Performance
-5.67%
Over The Past 5 Days
|
Ventyx Biosciences Inc
Profile
Ventyx Biosciences Inc is a biotechnology company that follows a research and development-focused business model. It aims to develop innovative biopharmaceutical products and therapeutic solutions by leveraging its expertise in various fields such as genetic engineering, drug discovery, and clinical trials. The company seeks to form strategic partnerships and licensing agreements to accelerate the commercialization of its products.
More about Ventyx Biosciences Inc 's Market Share
|
Cohbar Inc
Share Performance
0.00%
Over The Past 5 Days
|
Cohbar Inc
Profile
Cohbar Inc is a biotechnology company that focuses on the discovery and development of peptide-based therapeutics for the treatment of age-related diseases. Their business model revolves around leveraging their proprietary peptide technology platform and partnerships with pharmaceutical companies to advance and commercialize their drug candidates.
More about Cohbar Inc 's Market Share
|
Sarepta Therapeutics Inc
Share Performance
-38.26%
This Quarter
|
Sarepta Therapeutics Inc
Profile
Sarepta Therapeutics Inc's business model centers around the research, development, and commercialization of innovative genetic medicines for rare diseases, with a particular focus on Duchenne muscular dystrophy (DMD).
More about Sarepta Therapeutics Inc 's Market Share
|
Tiziana Life Sciences Ltd
Share Performance
+178.02%
One Year
|
Tiziana Life Sciences Ltd
Profile
Tiziana Life Sciences Ltd's business model focuses on the development and commercialization of innovative therapeutics in the field of immunology and oncology.
More about Tiziana Life Sciences Ltd's Market Share
|
Galapagos Nv
Share Performance
-7.78%
This Year
|
Galapagos Nv
Profile
Galapagos Nv's business model is centered around the development and commercialization of innovative medicines. They leverage their expertise in drug discovery and development to collaborate with partners in the healthcare industry, focusing on the advancement of novel therapies to address unmet medical needs.
More about Galapagos Nv's Market Share
|
Oncorus Inc
Share Performance
-49.60%
One Year
|
Oncorus Inc
Profile
Oncorus Inc is a biotechnology company that specializes in developing next-generation viral immunotherapies to treat various types of cancers. Their business model revolves around leveraging the power of oncolytic viruses, which selectively target and destroy cancer cells while stimulating an immune response against the tumor. Oncorus focuses on rigorous research, clinical development, and potential partnerships to advance their innovative therapies towards commercialization and widespread patient access.
More about Oncorus Inc 's Market Share
|
Corbus Pharmaceuticals Holdings Inc
Share Performance
-53.85%
This Quarter
|
Corbus Pharmaceuticals Holdings Inc
Profile
Corbus Pharmaceuticals Holdings Inc is a biopharmaceutical company focused on the development and commercialization of innovative therapies for inflammatory and fibrotic diseases. Their business model revolves around conducting research and clinical trials to identify potential drug candidates, obtaining regulatory approvals, and subsequently commercializing these drugs to generate revenue. They aim to address unmet medical needs by creating and marketing novel treatments for diseases such as systemic sclerosis, cystic fibrosis, and other inflammatory conditions.
More about Corbus Pharmaceuticals Holdings Inc 's Market Share
|
Kamada Ltd
Share Performance
+5.06%
This Year
|
Kamada Ltd
Profile
Kamada Ltd is a biopharmaceutical company that operates on a business model centered around developing and commercializing specialty plasma-derived therapeutics. The company focuses on leveraging its expertise in proprietary protein purification technology and plasma collection to produce and deliver high-quality therapeutic products. Kamada aims to address unmet medical needs in various therapeutic areas, providing innovative treatment options to patients worldwide.
More about Kamada Ltd 's Market Share
|
Innovation1 Biotech Inc
Share Performance
0.00%
Over The Past 5 Days
|
Innovation1 Biotech Inc
Profile
The business model of Innovation1 Biotech Inc involves developing and commercializing innovative biotechnological products and solutions for various industries. The company focuses on research, development, and manufacturing, aiming to provide cutting-edge biotech solutions that meet the needs of diverse markets.
More about Innovation1 Biotech Inc 's Market Share
|
Ligand Pharmaceuticals Inc
Share Performance
+49.96%
One Year
|
Ligand Pharmaceuticals Inc
Profile
Ligand Pharmaceuticals Inc operates on a business model focused on discovering and acquiring new drugs and technologies to license them to pharmaceutical companies. They generate revenue through licensing fees, milestone payments, and royalties from the sales of their partnered products. Their approach allows them to leverage their expertise and resources while minimizing risk, ultimately leading to long-term value creation for their shareholders.
More about Ligand Pharmaceuticals Inc's Market Share
|
Veru Inc
Share Performance
-22.34%
This Quarter
|
Veru Inc
Profile
Veru Inc operates as a pharmaceutical company primarily focused on developing and commercializing medicines for men's and women's health. With a combination of in-house research and partnerships, Veru Inc aims to address unmet medical needs by providing innovative therapies and products. Their business model encompasses both the development of new pharmaceuticals and the marketing and distribution of their existing products in the healthcare market.
More about Veru Inc 's Market Share
|
Lexicon Pharmaceuticals Inc
Share Performance
-53.47%
30 Days
|
Lexicon Pharmaceuticals Inc
Profile
Lexicon Pharmaceuticals Inc is a biopharmaceutical company that focuses on the discovery and development of innovative drugs. Their business model revolves around identifying potential drug targets, conducting research and preclinical studies to validate these targets, and subsequently developing drugs through clinical trials for various therapeutic areas. They also collaborate with pharmaceutical companies for joint development and commercialization efforts, aiming to bring these drugs to market and improve patient outcomes.
More about Lexicon Pharmaceuticals Inc 's Market Share
|
Fibrogen Inc
Share Performance
-36.43%
This Year
|
Fibrogen Inc
Profile
Fibrogen Inc's business model focuses on the development and commercialization of innovative therapeutics for unmet medical needs. They aim to discover and create treatments by leveraging their expertise in fibrosis and tissue regeneration. Fibrogen Inc collaborates with strategic partners and utilizes its extensive research and development capabilities to bring these therapies to market and improve the lives of patients.
More about Fibrogen Inc 's Market Share
|
Enanta Pharmaceuticals Inc
Share Performance
-55.98%
One Year
|
Enanta Pharmaceuticals Inc
Profile
Enanta Pharmaceuticals Inc's business model focuses on the research, development, and commercialization of innovative small molecule drugs targeting viral infections and liver diseases.
More about Enanta Pharmaceuticals Inc's Market Share
|
Summit Therapeutics Inc
Share Performance
+8.79%
This Quarter
|
Summit Therapeutics Inc
Profile
Summit Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of rare diseases. The company employs a research-driven business model, leveraging its proprietary technologies and expertise to identify and develop novel drugs targeting specific genetic mutations associated with these rare diseases. Summit Therapeutics Inc aims to bring its drug candidates through preclinical and clinical development stages and ultimately secure regulatory approval and commercialize them to benefit patients in need.
More about Summit Therapeutics Inc 's Market Share
|
Comera Life Sciences Holdings Inc
Share Performance
0.00%
This Quarter
|
Comera Life Sciences Holdings Inc
Profile
Comera Life Sciences Holdings Inc's business model involves the development and commercialization of innovative products and solutions in the field of life sciences and healthcare. They aim to address unmet medical needs by leveraging their expertise, research, and partnerships to bring advanced treatments and technologies to the market.
More about Comera Life Sciences Holdings Inc 's Market Share
|
Annexon Inc
Share Performance
-54.73%
This Year
|
Annexon Inc
Profile
Annexon Inc operates with a business model focused on developing therapeutic drugs to target and treat autoimmune and neurodegenerative disorders. The company conducts extensive research and preclinical studies to identify specific molecules that modulate the immune system and protect against neuroinflammation. Utilizing partnerships and collaborations, Annexon Inc aims to advance its drug candidates through clinical trials and potential commercialization to address unmet medical needs in the healthcare industry.
More about Annexon Inc 's Market Share
|
Spero Therapeutics Inc
Share Performance
-28.00%
This Year
|
Spero Therapeutics Inc
Profile
Spero Therapeutics Inc's business model focuses on developing novel antibiotics to combat drug-resistant bacterial infections.
More about Spero Therapeutics Inc 's Market Share
|
Connect Biopharma Holdings Limited
Share Performance
-33.44%
One Year
|
Connect Biopharma Holdings Limited
Profile
Connect Biopharma Holdings Limited is a biotechnology company that develops novel therapies for inflammatory diseases by targeting the immune system. Their business model includes research and development of innovative drugs, clinical trials, and partnerships with pharmaceutical companies for commercialization.
More about Connect Biopharma Holdings Limited's Market Share
|
Hcw Biologics Inc
Share Performance
-33.55%
This Year
|
Hcw Biologics Inc
Profile
HCW Biologics Inc is a biotechnology company that operates on a business model focused on the research, development, and commercialization of biologic therapies. The company primarily focuses on developing and manufacturing novel biological products for various medical conditions. Their business model involves collaboration with industry partners, conducting clinical trials, and securing regulatory approvals for the commercialization of their biologic therapies.
More about Hcw Biologics Inc 's Market Share
|
Zyversa Therapeutics Inc
Share Performance
-11.25%
Over The Past 5 Days
|
Zyversa Therapeutics Inc
Profile
Zyversa Therapeutics Inc's business model revolves around developing innovative therapies and treatments for various medical conditions.
More about Zyversa Therapeutics Inc 's Market Share
|
Moleculin Biotech Inc
Share Performance
-3.54%
Over The Past 5 Days
|
Moleculin Biotech Inc
Profile
Moleculin Biotech Inc is a biopharmaceutical company that develops innovative cancer therapies by targeting key enzymes and signaling pathways involved in the progression of tumors. Their business model revolves around conducting preclinical and clinical trials to advance their drug candidates, with a focus on maximizing therapeutic impact and commercial potential.
More about Moleculin Biotech Inc 's Market Share
|
Qualigen Therapeutics Inc
Share Performance
-25.24%
This Year
|
Qualigen Therapeutics Inc
Profile
Qualigen Therapeutics Inc's business model revolves around the development, manufacturing, and commercialization of novel therapeutics and diagnostic technologies aimed at improving patient outcomes, utilizing their broad intellectual property portfolio and strategic partnerships. They focus on bringing innovative solutions to market through targeted research and development efforts, while also seeking collaborations to maximize the impact of their products.
More about Qualigen Therapeutics Inc 's Market Share
|
Galmed Pharmaceuticals Ltd
Share Performance
-39.65%
One Year
|
Galmed Pharmaceuticals Ltd
Profile
Galmed Pharmaceuticals Ltd's business model focuses on the development and commercialization of innovative therapeutic solutions, particularly in the field of liver and metabolic diseases.
More about Galmed Pharmaceuticals Ltd 's Market Share
|
Gri Bio Inc
Share Performance
-51.56%
This Year
|
Gri Bio Inc
Profile
Gri Bio Inc's business model focuses on providing innovative biotechnology solutions.
More about Gri Bio Inc 's Market Share
|
Forte Biosciences Inc
Share Performance
-70.16%
This Year
|
Forte Biosciences Inc
Profile
Forte Biosciences Inc is a biotechnology company focused on developing and commercializing innovative solutions for the treatment of dermatological diseases. Their business model centers around researching, developing, and bringing to market products that address unmet needs in the field of skin health through their proprietary technology platform.
More about Forte Biosciences Inc 's Market Share
|
180 Life Sciences Corp
Share Performance
-43.55%
This Quarter
|
180 Life Sciences Corp
Profile
180 Life Sciences Corp is a biotechnology company engaged in the research and development of novel drugs that target inflammation and fibrosis to address various diseases such as fibrosis, inflammation, and pain.
More about 180 Life Sciences Corp's Market Share
|
Pieris Pharmaceuticals Inc
Share Performance
-20.14%
This Quarter
|
Pieris Pharmaceuticals Inc
Profile
Pieris Pharmaceuticals Inc. operates on a business model centered around the development and commercialization of innovative therapeutic proteins, particularly in the field of immuno-oncology.
More about Pieris Pharmaceuticals Inc 's Market Share
|
Evelo Biosciences Inc
Share Performance
0.00%
This Year
|
Evelo Biosciences Inc
Profile
Evelo Biosciences Inc is a biotechnology company focused on developing therapies for the treatment of various diseases. Their business model revolves around harnessing the potential of the body's own immune system through the development of monoclonal microbials. These microbials are designed to interact with the gut to elicit specific therapeutic effects, offering a novel approach to addressing medical conditions.
More about Evelo Biosciences Inc 's Market Share
|
Actavia Life Sciences Inc
Share Performance
0.00%
Over The Past 5 Days
|
Actavia Life Sciences Inc
Profile
Rasna Therapeutics Inc is a biotechnology company that focuses on developing innovative therapies for the treatment of cancer and other diseases. Their business model revolves around leveraging cutting-edge research and technology to discover and develop novel drug candidates. They aim to partner with pharmaceutical companies or license their intellectual property to bring their therapies to market and ultimately improve patient outcomes.
More about Actavia Life Sciences Inc 's Market Share
|
Protokinetix Incorporated
Share Performance
-2.00%
This Year
|
Protokinetix Incorporated
Profile
Protokinetix Incorporated's business model revolves around the commercialization of its proprietary technology, AAGP? (Antifreeze Protein Analog).
More about Protokinetix Incorporated's Market Share
|
Sangui Biotech International Inc
Share Performance
0.00%
30 Days
|
Sangui Biotech International Inc
Profile
Sangui Biotech International Inc's business model focuses on developing and commercializing innovative healthcare products. They aim to bring medical advancements and technological advancements together to improve patient care and outcomes. This is achieved through research, development, and the marketing of their healthcare solutions to various markets globally.
More about Sangui Biotech International Inc's Market Share
|
Regenerx Biopharmaceuticals inc
Share Performance
0.00%
Over The Past 5 Days
|
Regenerx Biopharmaceuticals inc
Profile
Regenerx Biopharmaceuticals Inc operates with a business model based on developing and commercializing innovative therapeutic products. They focus on utilizing regenerative medicine to address unmet medical needs in various therapeutic areas, including ophthalmology and dermatology. The company aims to identify promising drug candidates, conduct clinical trials, and ultimately bring their products to market to improve patients' lives.
More about Regenerx Biopharmaceuticals inc 's Market Share
|
Medicure Inc
Share Performance
0.00%
One Year
|
Medicure Inc
Profile
Medicure Inc operates as a pharmaceutical company with a business model that focuses on the research, development, and commercialization of innovative cardiovascular and other specialty pharmaceuticals. They aim to address unmet medical needs, improve patient outcomes, and deliver value to healthcare providers and consumers.
More about Medicure Inc 's Market Share
|
Dianthus Therapeutics Inc
Share Performance
-11.90%
This Year
|
Dianthus Therapeutics Inc
Profile
Dianthus Therapeutics Inc is a biotechnology company that focuses on developing novel genetic medicines for patients suffering from rare genetic diseases. Their business model revolves around leveraging cutting-edge gene therapy technologies to design and deliver innovative treatments. By partnering with academic institutions and utilizing a proprietary gene therapy platform, they aim to address unmet medical needs and provide potential new therapies for patients with genetic disorders.
More about Dianthus Therapeutics Inc 's Market Share
|
Acelyrin Inc
Share Performance
+0.73%
Over The Past 5 Days
|
Acelyrin Inc
Profile
Acelyrin Inc is a technology company that focuses on providing cutting-edge solutions in the healthcare industry. Their business model is centered around developing innovative software and hardware products that improve patient outcomes, enhance operational efficiency, and drive cost savings for healthcare organizations. By offering a range of advanced tools and services, Acelyrin Inc aims to revolutionize the healthcare sector and contribute to the overall advancement of digital health.
More about Acelyrin Inc 's Market Share
|
Azitra Inc
Share Performance
-8.10%
Over The Past 5 Days
|
Azitra Inc
Profile
Azitra Inc is a company that operates on a business model focused on developing and commercializing microbiome-based therapeutics for various skin conditions. It aims to use the potential of the human skin microbiome to develop innovative and effective treatments.
More about Azitra Inc 's Market Share
|
Dmk Pharmaceuticals Corporation
Share Performance
0.00%
This Quarter
|
Dmk Pharmaceuticals Corporation
Profile
DMK Pharmaceuticals Corporation has a business model focused on the development, manufacturing, and distribution of pharmaceutical products.
More about Dmk Pharmaceuticals Corporation's Market Share
|
Mereo Biopharma Group Plc
Share Performance
-2.29%
Over The Past 5 Days
|
Mereo Biopharma Group Plc
Profile
Mereo Biopharma Group Plc's business model focuses on the development and commercialization of innovative therapeutics for rare diseases.
More about Mereo Biopharma Group Plc's Market Share
|
Pyxis Oncology Inc
Share Performance
+0.90%
Over The Past 5 Days
|
Pyxis Oncology Inc
Profile
Pyxis Oncology Inc is a biotechnology company focused on developing innovative cancer therapies. Their business model revolves around leveraging novel insights into the immune system to develop a pipeline of potential immunotherapies for cancer treatment. Pyxis Oncology aims to collaborate with strategic partners to advance their therapies through preclinical and clinical development, ultimately aiming to improve patient outcomes in the field of oncology.
More about Pyxis Oncology Inc 's Market Share
|
Jazz Pharmaceuticals Plc
Share Performance
+13.58%
This Year
|
Jazz Pharmaceuticals Plc
Profile
Jazz Pharmaceuticals Plc is a biopharmaceutical company focused on developing and commercializing innovative therapies for a range of medical conditions. Their business model revolves around conducting extensive research and development to identify novel molecules and compounds that can address unmet medical needs. By leveraging strategic partnerships, acquisitions, and licensing agreements, they aim to bring these therapies to market and provide valuable treatment options to patients worldwide.
More about Jazz Pharmaceuticals Plc's Market Share
|
Adhera Therapeutics Inc
Share Performance
-95.83%
This Quarter
|
Adhera Therapeutics Inc
Profile
Adhera Therapeutics Inc's business model revolves around developing and commercializing innovative medication adherence solutions. They leverage technology to provide patients with tools and support systems that help them adhere to prescribed treatments. By focusing on improving medication adherence rates, Adhera Therapeutics aims to enhance patient outcomes and reduce healthcare costs for both individuals and the healthcare industry.
More about Adhera Therapeutics Inc 's Market Share
|
Royalty Pharma Plc
Share Performance
+2.79%
30 Days
|
Royalty Pharma Plc
Profile
Royalty Pharma Plc operates as a pharmaceutical investment company, focusing on acquiring and managing royalty interests in approved drugs. Their business model primarily revolves around purchasing existing royalty streams in exchange for upfront payments, allowing them to generate ongoing cash flows from the sales of these drugs. They aim to provide liquidity to stakeholders, such as biotech and pharmaceutical companies, by offering a financial alternative to traditional financing options.
More about Royalty Pharma Plc's Market Share
|
Alnylam Pharmaceuticals Inc
Share Performance
+3.30%
This Quarter
|
Alnylam Pharmaceuticals Inc
Profile
Alnylam Pharmaceuticals Inc's business model focuses on developing and commercializing RNA interference (RNAi) therapeutics.
More about Alnylam Pharmaceuticals Inc 's Market Share
|
Ionis Pharmaceuticals Inc
Share Performance
-5.65%
This Year
|
Ionis Pharmaceuticals Inc
Profile
Ionis Pharmaceuticals Inc is a biopharmaceutical company that operates on a two-fold business model. Firstly, the company focuses on discovering and developing antisense drugs, utilizing a unique RNA-targeted technology. Secondly, Ionis collaborates with established pharmaceutical partners to license and commercialize their drugs, allowing for maximum reach and potential commercial success.
More about Ionis Pharmaceuticals Inc's Market Share
|
Ptc Therapeutics inc
Share Performance
+3.91%
Over The Past 5 Days
|
Ptc Therapeutics inc
Profile
PTC Therapeutics Inc's business model revolves around the research, development, and commercialization of innovative treatments for rare and genetic diseases.
More about Ptc Therapeutics inc 's Market Share
|
Akero Therapeutics Inc
Share Performance
+1.16%
Over The Past 5 Days
|
Akero Therapeutics Inc
Profile
Akero Therapeutics Inc is a biotechnology company that focuses on the development of breakthrough treatments for non-alcoholic steatohepatitis (NASH) and other serious metabolic disorders. Their business model revolves around advancing their proprietary drug candidates through preclinical and clinical stages to ultimately bring them to market, partnering with leading academic institutions and leveraging scientific expertise to drive innovation in the field. Akero Therapeutics aims to address the significant unmet medical needs in these areas and create value for patients, healthcare providers, and shareholders.
More about Akero Therapeutics Inc 's Market Share
|
Nuvation Bio Inc
Share Performance
-14.78%
30 Days
|
Nuvation Bio Inc
Profile
Nuvation Bio Inc's business model is centered around the development of novel therapies for the treatment of cancer and other diseases.
More about Nuvation Bio Inc 's Market Share
|
Vera Therapeutics Inc
Share Performance
-5.78%
30 Days
|
Vera Therapeutics Inc
Profile
Vera Therapeutics Inc is a pharmaceutical company that specializes in developing and commercializing innovative therapies for patients with rare and serious diseases. Their business model focuses on researching and developing novel drug candidates, conducting clinical trials, and obtaining regulatory approvals to bring their products to market. By targeting niche patient populations with unmet medical needs, they aim to provide effective treatment options and improve patient outcomes.
More about Vera Therapeutics Inc 's Market Share
|
Pepgen Inc
Share Performance
-21.29%
Over The Past 5 Days
|
Pepgen Inc
Profile
Pepgen Inc is a biotechnology company that operates on a business model focused on developing and commercializing transformative therapies for genetic diseases. They leverage their expertise in synthetic biology and gene editing technologies to create novel peptide-based therapies that can address previously untreatable genetic conditions. Pepgen Inc aims to partner with healthcare organizations and pharmaceutical companies to bring their innovative treatments to market.
More about Pepgen Inc 's Market Share
|
Lianbio
Share Performance
-92.40%
This Quarter
|
Lianbio
Profile
LianBio is a biopharmaceutical company that focuses on accelerating the development and commercialization of innovative medicines in the Chinese market. They collaborate with global partners to identify and acquire promising drug candidates, providing them with regulatory expertise and commercialization capabilities. By leveraging their deep understanding of the Chinese healthcare landscape, LianBio aims to bridge the gap between global innovation and Chinese patient needs.
More about Lianbio's Market Share
|
Cormedix Inc
Share Performance
+178.46%
One Year
|
Cormedix Inc
Profile
Cormedix Inc operates on a business model centered around the research, development, and commercialization of innovative pharmaceutical products for the prevention and treatment of infectious and inflammatory diseases. The company focuses on utilizing its expertise in antimicrobial and immunological technology to address unmet medical needs. By leveraging collaborations, partnerships, and regulatory approvals, Cormedix aims to bring its products to market and improve healthcare outcomes for patients.
More about Cormedix Inc's Market Share
|
Matinas Biopharma Holdings Inc
Share Performance
-7.99%
This Year
|
Matinas Biopharma Holdings Inc
Profile
Matinas Biopharma Holdings Inc operates as a clinical-stage biopharmaceutical company. Their business model centers around developing therapeutics through the utilization of lipid nano-crystal (LNC) platform technologies. These technologies enable the effective delivery of drugs to improve patient outcomes in various diseases and conditions such as fungal infections, viral infections, and cancer.
More about Matinas Biopharma Holdings Inc 's Market Share
|
Inflarx N v
Share Performance
-33.86%
30 Days
|
Inflarx N v
Profile
Inflarx N is a company that operates on a B2B (business-to-business) model. They offer a range of services and products such as software solutions, data analytics, and consulting to businesses in the technology sector. Their revenue primarily comes from subscription fees, licensing, and consulting fees.
More about Inflarx N v 's Market Share
|
9 Meters Biopharma Inc
Share Performance
-94.22%
This Quarter
|
9 Meters Biopharma Inc
Profile
9 Meters Biopharma Inc is a pharmaceutical company that focuses on developing and commercializing innovative therapies for gastrointestinal diseases. Their business model revolves around conducting research, clinical trials, and gaining regulatory approvals for their drug candidates. They then aim to license or partner with larger pharmaceutical companies for manufacturing, marketing, and distribution of their approved treatments.
More about 9 Meters Biopharma Inc 's Market Share
|
Dice Therapeutics Inc
Share Performance
+51.77%
This Year
|
Dice Therapeutics Inc
Profile
Dice Therapeutics Inc. is a biotechnology company that focuses on developing novel therapies for various diseases. Their business model revolves around leveraging innovative science and technology to identify and target disease drivers, aiming to discover and develop drug candidates that can offer substantial clinical benefits to patients. Through strategic partnerships and collaborations, they aim to bring their therapies to the market efficiently and meet the unmet medical needs in the healthcare industry.
More about Dice Therapeutics Inc 's Market Share
|
Centessa Pharmaceuticals Plc
Share Performance
-5.07%
This Quarter
|
Centessa Pharmaceuticals Plc
Profile
Centessa Pharmaceuticals Plc operates as a biopharmaceutical company that focuses on the discovery and development of innovative medicines. Their business model centers around leveraging a decentralized approach, with multiple subsidiary companies working autonomously to accelerate the research and development of potential therapeutics across various disease areas. By bringing together diverse expertise and resources, Centessa aims to efficiently advance breakthrough therapies and deliver impactful solutions to patients in need.
More about Centessa Pharmaceuticals Plc's Market Share
|
Biovie Inc
Share Performance
+102.64%
One Year
|
Biovie Inc
Profile
Biovie Inc is a biotechnology company that aims to develop advanced therapeutic solutions for various diseases. They have a unique business model that focuses on research and development of innovative drugs, strategic partnerships and collaborations with other organizations, along with potential commercialization of their products to generate revenue. Their goal is to create groundbreaking medical treatments that improve the quality of life for patients.
More about Biovie Inc 's Market Share
|
Keros Therapeutics Inc
Share Performance
-83.43%
One Year
|
Keros Therapeutics Inc
Profile
Keros Therapeutics Inc's business model is focused on the development of therapeutics to address significant unmet needs in various diseases by targeting specific protein elements within the cell signaling pathways.
More about Keros Therapeutics Inc 's Market Share
|
Scpharmaceuticals Inc
Share Performance
-11.21%
This Quarter
|
Scpharmaceuticals Inc
Profile
Scpharmaceuticals Inc's business model involves the development and commercialization of innovative pharmaceutical products. They aim to create and bring to market novel therapies that improve patient access, safety, and convenience. Their approach focuses on leveraging their proprietary technology to develop and deliver drugs in a unique and effective manner.
More about Scpharmaceuticals Inc 's Market Share
|
Contrafect Corporation
Share Performance
-16.39%
Over The Past 5 Days
|
Contrafect Corporation
Profile
ContraFect Corporation is a biotechnology company that focuses on the development of protein and antibody-based therapies to treat drug-resistant infectious diseases.
More about Contrafect Corporation's Market Share
|
Arbutus Biopharma Corp
Share Performance
+3.12%
This Quarter
|
Arbutus Biopharma Corp
Profile
Arbutus Biopharma Corp is a biopharmaceutical company focused on discovering and developing innovative therapies for patients suffering from Hepatitis B. They aim to utilize their proprietary technologies to both advance their internal pipeline and collaborate with partners to develop a cure for Hepatitis B. Their business model revolves around leveraging their expertise and strategic partnerships to create effective treatments that address the unmet needs of Hepatitis B patients.
More about Arbutus Biopharma Corp's Market Share
|
Nurix Therapeutics Inc
Share Performance
+2.06%
Over The Past 5 Days
|
Nurix Therapeutics Inc
Profile
Nurix Therapeutics Inc's business model involves developing targeted protein degradation therapies to treat diseases by modulating the body's cellular protein levels.
More about Nurix Therapeutics Inc 's Market Share
|
Cytodyn inc
Share Performance
+98.11%
This Year
|
Cytodyn inc
Profile
Cytodyn Inc is a biotechnology company that focuses on the development and commercialization of innovative treatments for a range of diseases, including cancer and viral infections. The company primarily generates revenue through the licensing and sale of its therapeutics to medical institutions and pharmaceutical companies. Cytodyn's business model revolves around the research and development of novel drugs, conducting clinical trials, and forming strategic partnerships to bring their innovative treatments to market.
More about Cytodyn inc 's Market Share
|
Horizon Therapeutics Public Limited Company
Share Performance
+0.81%
30 Days
|
Horizon Therapeutics Public Limited Company
Profile
Horizon Therapeutics Public Limited Company operates as a biopharmaceutical company that develops and commercializes medicines for the treatment of rare diseases. Their business model revolves around acquiring and developing innovative therapies and then distributing them to patients in need. By focusing on rare diseases with high unmet needs, Horizon Therapeutics aims to provide life-changing treatments to underserved patient populations.
More about Horizon Therapeutics Public Limited Company's Market Share
|
Nexien Biopharma Inc
Share Performance
+150.00%
Over The Past 5 Days
|
Nexien Biopharma Inc
Profile
Nexien Biopharma Inc operates as a biotechnology company focused on the development and commercialization of innovative therapies for various medical conditions. They aim to use their expertise in biopharmaceutical research to bring novel treatments to market, improving patient outcomes and meeting unmet medical needs.
More about Nexien Biopharma Inc 's Market Share
|
Humanigen Inc
Share Performance
-99.00%
This Year
|
Humanigen Inc
Profile
Humanigen Inc is a biopharmaceutical company that develops and commercializes immunotherapy treatments to address serious diseases and medical conditions.
More about Humanigen Inc's Market Share
|
Zymeworks Inc
Share Performance
-8.56%
This Quarter
|
Zymeworks Inc
Profile
Zymeworks Inc is a biotechnology company that operates on a licensing and collaboration business model. They primarily generate revenue through partnerships and collaborations with pharmaceutical and biotechnology companies, providing access to their proprietary drug development platform and expertise in protein engineering. This enables them to advance the development of novel bi-specific antibodies and therapeutic proteins for the treatment of various diseases and medical conditions.
More about Zymeworks Inc 's Market Share
|
Ultragenyx Pharmaceutical Inc
Share Performance
-16.63%
One Year
|
Ultragenyx Pharmaceutical Inc
Profile
Ultragenyx Pharmaceutical Inc's business model focuses on developing and commercializing innovative therapies for rare genetic diseases.
More about Ultragenyx Pharmaceutical Inc 's Market Share
|
Innoviva Inc
Share Performance
-4.55%
30 Days
|
Innoviva Inc
Profile
Innoviva Inc's business model revolves around the development and commercialization of pharmaceutical products. The company primarily focuses on creating strategic collaborations and partnerships with biopharmaceutical companies to advance innovative therapies. Innoviva generates revenue through royalty payments received based on the sales of its partnered products.
More about Innoviva Inc 's Market Share
|
Insmed Inc
Share Performance
+2.90%
Over The Past 5 Days
|
Insmed Inc
Profile
Insmed Inc operates as a biopharmaceutical company focused on developing novel therapies for serious and rare diseases. The company's business model revolves around discovering, developing, and commercializing innovative therapies to address significant unmet medical needs. Insmed Inc's efforts primarily center around leveraging its expertise in biologics and advanced drug delivery technologies to improve the lives of patients with rare pulmonary diseases.
More about Insmed Inc's Market Share
|
Xencor Inc
Share Performance
+5.56%
Over The Past 5 Days
|
Xencor Inc
Profile
Xencor Inc is a biotechnology company that primarily focuses on the development of therapeutic antibodies. Their business model revolves around utilizing their proprietary XmAb? technology to engineer antibodies with enhanced properties for the treatment of various diseases. They collaborate with pharmaceutical companies to develop and commercialize these antibody therapeutics, generating revenue through upfront payments, milestone payments, and royalties.
More about Xencor Inc's Market Share
|
Pharming Group N v
Share Performance
-14.67%
This Year
|
Pharming Group N v
Profile
Pharming Group N.V. operates on a business model focused on the development, production, and commercialization of innovative therapeutic products for the treatment of rare diseases and unmet medical needs. The company primarily generates revenue by selling its approved products in various geographic markets and through strategic collaborations with pharmaceutical partners. Pharming Group N.V. also engages in research and development activities to expand its product pipeline and explore potential new treatments.
More about Pharming Group N v 's Market Share
|
Eli Lilly And Company
Share Performance
+9.39%
One Year
|
Eli Lilly And Company
Profile
Eli Lilly and Company operates as a global pharmaceutical firm that focuses on developing innovative medicines in areas such as diabetes, oncology, and neurodegeneration. Their business model emphasizes research and development, strategic partnerships, and a strong commitment to improving patient outcomes through advanced therapeutics.
More about Eli Lilly And Company's Market Share
|
Sanofi
Share Performance
+21.08%
One Year
|
Sanofi
Profile
Sanofi's business model revolves around the development, production, and distribution of pharmaceutical products. They aim to innovate and provide healthcare solutions across various therapeutic areas to improve patients' lives worldwide. Sanofi collaborates with partners and healthcare professionals to ensure effective delivery of their products and to address evolving patient needs.
More about Sanofi's Market Share
|
Kiniksa Pharmaceuticals International plc
Share Performance
+19.41%
This Year
|
Kiniksa Pharmaceuticals International plc
Profile
Kiniksa Pharmaceuticals Ltd is a biopharmaceutical company focused on developing and commercializing therapeutics for patients with debilitating diseases and unmet medical needs. Their business model revolves around identifying potential drug candidates, conducting rigorous research and development, and ultimately bringing these drugs to market to provide innovative treatment options. They generate revenue through the sale of their products and collaborations with other companies for the development and commercialization of their therapies.
More about Kiniksa Pharmaceuticals International plc's Market Share
|
Galecto Inc
Share Performance
-78.38%
One Year
|
Galecto Inc
Profile
Galecto Inc operates on a business model that focuses on developing novel therapeutics based on galectin inhibitors, targeting fibrosis and inflammation-related diseases. The company aims to bring these innovative drugs to market by leveraging their expertise in drug discovery and development, while forming strategic partnerships and collaborations within the pharmaceutical industry.
More about Galecto Inc 's Market Share
|
Renovorx Inc
Share Performance
+0.61%
Over The Past 5 Days
|
Renovorx Inc
Profile
Renovorx Inc is a medical technology company specializing in the development of innovative treatments for cardiovascular diseases. Their business model focuses on creating and commercializing minimally invasive therapies for patients suffering from conditions like myocardial infarction and heart failure. By leveraging cutting-edge medical devices and procedures, Renovorx aims to provide effective and efficient treatments that can significantly improve patient outcomes and quality of life.
More about Renovorx Inc 's Market Share
|
Opko Health Inc
Share Performance
+95.70%
One Year
|
Opko Health Inc
Profile
Opko Health Inc is a biotechnology and pharmaceutical company that operates through various business segments. The company primarily focuses on diagnostics, developing and commercializing novel diagnostic tests for various conditions. Additionally, Opko Health engages in the production and sale of pharmaceuticals and vaccines, as well as the research and development of new medical technologies.
More about Opko Health Inc 's Market Share
|
Alpine Immune Sciences Inc
Share Performance
+113.86%
This Quarter
|
Alpine Immune Sciences Inc
Profile
Alpine Immune Sciences Inc is a biotechnology company focused on developing immunotherapies to treat cancer and autoimmune diseases. Their business model involves identifying unique protein targets and using their proprietary technology platform to engineer and develop novel therapeutic antibodies that modulate the immune system. They aim to partner with pharmaceutical companies for the clinical development and commercialization of their product candidates.
More about Alpine Immune Sciences Inc 's Market Share
|
United Therapeutics Corporation
Share Performance
-12.94%
This Year
|
United Therapeutics Corporation
Profile
United Therapeutics Corporation's business model revolves around the development and commercialization of innovative therapeutics for treating rare diseases and chronic conditions. They focus on researching, manufacturing, marketing, and distributing their specialized pharmaceutical and medical products to healthcare providers and patients globally.
More about United Therapeutics Corporation's Market Share
|
Acer Therapeutics Inc
Share Performance
-42.60%
One Year
|
Acer Therapeutics Inc
Profile
Acer Therapeutics Inc is a pharmaceutical company that operates on a business model focused on developing and commercializing innovative therapies for rare and severe diseases. They aim to identify unmet medical needs and provide treatment options for patients through strategic partnerships, clinical development, and commercialization efforts.
More about Acer Therapeutics Inc 's Market Share
|
Travere Therapeutics Inc
Share Performance
+5.58%
Over The Past 5 Days
|
Travere Therapeutics Inc
Profile
Travere Therapeutics Inc operates under a business model focused on developing and commercializing therapies for rare diseases. They aim to provide innovative treatments and solutions for patients suffering from these conditions. The company primarily focuses on research, development, and distribution of pharmaceutical products tailored for rare diseases.
More about Travere Therapeutics Inc 's Market Share
|
Mira Pharmaceuticals Inc
Share Performance
+3.39%
Over The Past 5 Days
|
Mira Pharmaceuticals Inc
Profile
Mira Pharmaceuticals Inc's business model is focused on the development and sale of pharmaceutical products, with a particular emphasis on research and innovation in the healthcare industry.
More about Mira Pharmaceuticals Inc 's Market Share
|
Reata Pharmaceuticals Inc
Share Performance
+77.49%
This Quarter
|
Reata Pharmaceuticals Inc
Profile
Reata Pharmaceuticals Inc is a biopharmaceutical company focused on developing innovative therapeutics for serious and life-threatening diseases. Their business model centers around the discovery, development, and commercialization of novel drugs based on their proprietary technology platform. Reata Pharmaceuticals aims to bring transformative treatments to patients, partnering with other organizations and leveraging their expertise to deliver value to stakeholders.
More about Reata Pharmaceuticals Inc 's Market Share
|
Savara Inc
Share Performance
-11.46%
This Quarter
|
Savara Inc
Profile
Savara Inc operates as a biopharmaceutical company that focuses on developing and commercializing therapies for rare respiratory diseases. Their business model revolves around conducting research and development activities to identify and develop novel treatments, obtaining regulatory approvals for their products, and subsequently marketing and selling these therapies to patients and healthcare providers. By targeting unmet medical needs in the respiratory field, Savara aims to improve the lives of individuals suffering from these rare diseases.
More about Savara Inc 's Market Share
|
Ngm Biopharmaceuticals Inc
Share Performance
+23.20%
This Year
|
Ngm Biopharmaceuticals Inc
Profile
Ngm Biopharmaceuticals Inc is a biotechnology company that focuses on discovering and developing innovative therapeutics for various diseases. They primarily earn revenue through partnerships, collaborations, research grants, and licensing agreements with pharmaceutical companies and academic institutions.
More about Ngm Biopharmaceuticals Inc 's Market Share
|
Kezar Life Sciences Inc
Share Performance
-4.94%
Over The Past 5 Days
|
Kezar Life Sciences Inc
Profile
Kezar Life Sciences Inc is a biotechnology company that focuses on developing novel small molecule therapeutics. Their business model revolves around the discovery and development of innovative drugs to target autoimmune and inflammatory disorders, aiming to address unmet medical needs. They primarily operate by conducting extensive research and conducting clinical trials to deliver effective treatments for patients.
More about Kezar Life Sciences Inc 's Market Share
|
Amylyx Pharmaceuticals Inc
Share Performance
+29.97%
One Year
|
Amylyx Pharmaceuticals Inc
Profile
Amylyx Pharmaceuticals Inc's business model revolves around researching, developing, and commercializing potential therapies for neurodegenerative diseases. They aim to identify promising drug candidates, conduct preclinical and clinical trials, and ultimately gain regulatory approval to market and sell their products. By focusing on innovative treatments, Amylyx Pharmaceuticals Inc aims to address unmet medical needs in the field of neurodegenerative disorders.
More about Amylyx Pharmaceuticals Inc 's Market Share
|
Gossamer Bio Inc
Share Performance
+39.18%
This Year
|
Gossamer Bio Inc
Profile
Gossamer Bio Inc operates with a business model focused on the development and commercialization of novel therapies for patients with complex diseases. They leverage extensive scientific expertise and strategic partnerships to identify and advance a diverse pipeline of innovative medicines. Their goal is to deliver transformative therapies that address significant unmet medical needs and improve patient outcomes.
More about Gossamer Bio Inc 's Market Share
|
Biomarin Pharmaceutical Inc
Share Performance
+9.05%
This Quarter
|
Biomarin Pharmaceutical Inc
Profile
Biomarin Pharmaceutical Inc operates as a biotechnology company, specializing in the development and commercialization of innovative therapies for rare genetic diseases. Their business model revolves around conducting extensive research and development to identify and address unmet medical needs, manufacturing and marketing their approved products, and collaborating with strategic partners to maximize the reach and impact of their therapies worldwide. By focusing on rare diseases, Biomarin leverages their expertise to provide targeted and innovative treatments, ultimately improving the lives of patients in need.
More about Biomarin Pharmaceutical Inc's Market Share
|
Assembly Biosciences Inc
Share Performance
-29.72%
This Quarter
|
Assembly Biosciences Inc
Profile
Assembly Biosciences Inc's business model revolves around the discovery, development, and commercialization of innovative oral therapeutics for the treatment of viral diseases of the liver. Their approach focuses on using targeted antiviral therapeutics to address unmet medical needs and improve patient outcomes.
More about Assembly Biosciences Inc 's Market Share
|
Aptevo Therapeutics Inc
Share Performance
-43.99%
This Quarter
|
Aptevo Therapeutics Inc
Profile
Aptevo Therapeutics Inc operates as a biotechnology company that focuses on the development of novel oncology and hematology therapeutics. The company primarily generates revenue through the sale of its products and potential collaborations with other pharmaceutical companies.
More about Aptevo Therapeutics Inc 's Market Share
|
Theratechnologies Inc
Share Performance
-9.50%
This Quarter
|
Theratechnologies Inc
Profile
Theratechnologies Inc.'s business model revolves around developing and commercializing innovative therapies for unmet medical needs.
More about Theratechnologies Inc 's Market Share
|
Xtl Biopharmaceuticals Ltd
Share Performance
-22.37%
30 Days
|
Xtl Biopharmaceuticals Ltd
Profile
Xtl Biopharmaceuticals Ltd's business model revolves around developing and commercializing innovative biopharmaceutical products.
More about Xtl Biopharmaceuticals Ltd 's Market Share
|
Amicus Therapeutics inc
Share Performance
-5.02%
30 Days
|
Amicus Therapeutics inc
Profile
Amicus Therapeutics Inc is a biopharmaceutical company that focuses on the development and commercialization of therapies for rare and orphan diseases.
More about Amicus Therapeutics inc 's Market Share
|
Integrated Biopharma Inc
Share Performance
0.00%
One Year
|
Integrated Biopharma Inc
Profile
Integrated Biopharma Inc's business model can be described as a vertically integrated health and wellness company focused on producing and distributing nutritional and dietary supplements.
More about Integrated Biopharma Inc's Market Share
|
Indaptus Therapeutics Inc
Share Performance
-11.15%
This Year
|
Indaptus Therapeutics Inc
Profile
Indaptus Therapeutics Inc's business model focuses on developing and commercializing innovative therapies in the healthcare industry.
More about Indaptus Therapeutics Inc 's Market Share
|
Eledon Pharmaceuticals Inc
Share Performance
-5.75%
Over The Past 5 Days
|
Eledon Pharmaceuticals Inc
Profile
Eledon Pharmaceuticals Inc is a pharmaceutical company that operates on a research and development model, focusing on the discovery and development of innovative drugs in various therapeutic areas. They aim to bring new drugs to market by conducting extensive research, clinical trials, and partnering with other pharmaceutical companies for manufacturing and distribution.
More about Eledon Pharmaceuticals Inc 's Market Share
|
Fortress Biotech Inc
Share Performance
-19.81%
This Year
|
Fortress Biotech Inc
Profile
Fortress Biotech Inc operates as a biopharmaceutical company that acquires, develops, and commercializes novel pharmaceutical and biotechnology products. Their business model focuses on partnering with academic institutions and biotech companies to advance preclinical and clinical-stage therapies for various diseases. Additionally, they aim to leverage their expertise and partnerships to improve the development process and bring innovative treatments to patients in need.
More about Fortress Biotech Inc 's Market Share
|
Applied Therapeutics Inc
Share Performance
-92.68%
One Year
|
Applied Therapeutics Inc
Profile
Applied Therapeutics Inc is a pharmaceutical company that focuses on developing and commercializing novel therapies to treat metabolic diseases. They employ a combination of in-house research and external collaborations to identify and advance potential drug candidates through clinical trials and regulatory approvals.
More about Applied Therapeutics Inc 's Market Share
|
Palatin Technologies Inc
Share Performance
-3.59%
Over The Past 5 Days
|
Palatin Technologies Inc
Profile
Palatin Technologies Inc has a business model focused on developing and commercializing innovative medicines in the field of reproductive healthcare and sexual dysfunction. The company's revenue streams primarily come from partnerships, licensing agreements, and product sales.
More about Palatin Technologies Inc 's Market Share
|
Diamedica Therapeutics Inc
Share Performance
-19.81%
This Quarter
|
Diamedica Therapeutics Inc
Profile
Diamedica Therapeutics Inc's business model focuses on developing and commercializing innovative therapies to improve patient outcomes in areas of unmet medical needs.
More about Diamedica Therapeutics Inc 's Market Share
|
Altamira Therapeutics Ltd
Share Performance
-60.00%
This Quarter
|
Altamira Therapeutics Ltd
Profile
Altamira Therapeutics Ltd's business model revolves around developing and commercializing innovative therapeutics.
More about Altamira Therapeutics Ltd 's Market Share
|
Calcimedica Inc
Share Performance
-45.17%
One Year
|
Calcimedica Inc
Profile
Calcimedica Inc is a biopharmaceutical company that focuses on the research and development of small molecule drugs to treat a range of diseases caused by calcium dysregulation. Their business model involves identifying potential drug candidates, conducting preclinical and clinical trials, and eventually commercializing these drugs to address unmet medical needs.
More about Calcimedica Inc 's Market Share
|
Xenetic Biosciences Inc
Share Performance
-13.92%
One Year
|
Xenetic Biosciences Inc
Profile
Xenetic Biosciences Inc is a biopharmaceutical company that focuses on developing personalized therapeutics with the potential to improve patient outcomes. The company employs a business model centered around leveraging its proprietary drug development platform to partner with pharmaceutical companies and advance novel drug candidates through preclinical and clinical stages.
More about Xenetic Biosciences Inc 's Market Share
|
Cyclerion Therapeutics Inc
Share Performance
-15.05%
This Quarter
|
Cyclerion Therapeutics Inc
Profile
Cyclerion Therapeutics Inc's business model focuses on developing and commercializing innovative therapies for serious and chronic diseases by targeting soluble guanylate cyclase (sGC).
More about Cyclerion Therapeutics Inc 's Market Share
|
Synlogic Inc
Share Performance
-6.74%
30 Days
|
Synlogic Inc
Profile
Synlogic Inc's business model revolves around utilizing synthetic biology to develop innovative microbial engineering solutions. They focus on developing Synthetic Biotic medicines, which are living medicines designed to treat diseases by targeting specific metabolic or immuno-inflammatory pathways in the body.
More about Synlogic Inc 's Market Share
|
Acurx Pharmaceuticals inc
Share Performance
-40.99%
30 Days
|
Acurx Pharmaceuticals inc
Profile
Acurx Pharmaceuticals Inc. operates by developing and commercializing novel antibiotics to address the growing problem of bacterial antibiotic resistance. The company focuses on targeting serious and life-threatening infections caused by multi-drug-resistant bacterial strains. Acurx Pharmaceuticals aims to bring innovative solutions to market through research and development, strategic partnerships, and a strong emphasis on improving patient outcomes.
More about Acurx Pharmaceuticals inc 's Market Share
|
Xbiotech Inc
Share Performance
-17.27%
This Year
|
Xbiotech Inc
Profile
Xbiotech Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic antibodies. They seek to address unmet medical needs by leveraging their proprietary True Human antibody technology.
More about Xbiotech Inc 's Market Share
|
Edesa Biotech Inc
Share Performance
+3.35%
Over The Past 5 Days
|
Edesa Biotech Inc
Profile
Edesa Biotech Inc's business model focuses on the development and commercialization of innovative therapeutics in the field of dermatology and gastrointestinal diseases.
More about Edesa Biotech Inc 's Market Share
|
Coya Therapeutics Inc
Share Performance
-0.31%
Over The Past 5 Days
|
Coya Therapeutics Inc
Profile
Coya Therapeutics Inc's business model focuses on developing and providing therapeutic solutions for various medical conditions or diseases.
More about Coya Therapeutics Inc 's Market Share
|
Addex Therapeutics Ltd
Share Performance
-0.78%
30 Days
|
Addex Therapeutics Ltd
Profile
Addex Therapeutics Ltd operates under a business model focused on the discovery and development of novel, orally available small molecule drugs that target specific receptors in the central nervous system. The company combines its expertise in medicinal chemistry and drug development to advance its pipeline of potential therapeutics for neurological disorders.
More about Addex Therapeutics Ltd's Market Share
|
Avalo Therapeutics inc
Share Performance
+78.70%
One Year
|
Avalo Therapeutics inc
Profile
Avalo Therapeutics Inc is a biotechnology company that focuses on developing novel cancer therapies. Their business model revolves around discovering and advancing targeted therapeutics using their proprietary platform technology. They aim to bring innovative treatments to patients by employing a combination of scientific expertise, strategic collaborations, and clinical development.
More about Avalo Therapeutics inc 's Market Share
|
Fulcrum Therapeutics Inc
Share Performance
-69.15%
One Year
|
Fulcrum Therapeutics Inc
Profile
Fulcrum Therapeutics Inc operates as a biopharmaceutical company that focuses on developing personalized therapies for genetically defined diseases. Their business model involves leveraging their proprietary product engine to identify and target specific gene regulatory networks to address the root causes of diseases.
More about Fulcrum Therapeutics Inc 's Market Share
|
Theravance Biopharma inc
Share Performance
+0.86%
This Year
|
Theravance Biopharma inc
Profile
Theravance Biopharma Inc's business model focuses on developing and commercializing innovative therapeutics to address unmet medical needs in various therapeutic areas.
More about Theravance Biopharma inc 's Market Share
|
Third Harmonic Bio Inc
Share Performance
-67.25%
This Quarter
|
Third Harmonic Bio Inc
Profile
Third Harmonic Bio Inc's business model centers around developing and commercializing innovative therapeutic solutions through the utilization of bioinformatics and genomics.
More about Third Harmonic Bio Inc 's Market Share
|
Immunome Inc
Share Performance
-12.53%
30 Days
|
Immunome Inc
Profile
Immunome Inc is a biotechnology company that focuses on developing novel immunotherapies. Their business model revolves around leveraging their proprietary discovery engine to identify therapeutic antibodies for infectious diseases and cancer. By collaborating with partners and through their own clinical development efforts, they aim to bring these promising treatments to the market.
More about Immunome Inc's Market Share
|
Kalvista Pharmaceuticals Inc
Share Performance
+12.04%
30 Days
|
Kalvista Pharmaceuticals Inc
Profile
Kalvista Pharmaceuticals Inc's business model primarily focuses on the development and commercialization of novel small molecule therapies for various diseases. They strive to discover and develop innovative treatments to address unmet medical needs, and aim to bring these therapies to market efficiently and effectively.
More about Kalvista Pharmaceuticals Inc 's Market Share
|
Tenax Therapeutics Inc
Share Performance
-4.03%
30 Days
|
Tenax Therapeutics Inc
Profile
Tenax Therapeutics Inc is a pharmaceutical company that specializes in developing and commercializing products for critical care patients with cardiovascular and pulmonary diseases. Their business model revolves around conducting research and clinical trials to bring innovative therapies to market. They generate revenue primarily by licensing their products to other pharmaceutical companies or through direct sales to hospitals and healthcare providers.
More about Tenax Therapeutics Inc 's Market Share
|
Bicycle Therapeutics Plc
Share Performance
-35.35%
This Quarter
|
Bicycle Therapeutics Plc
Profile
Bicycle Therapeutics Plc's business model is centered around the development and commercialization of novel therapeutics using its proprietary bicyclic peptide platform.
More about Bicycle Therapeutics Plc's Market Share
|
Xoma Royalty Corporation
Share Performance
-19.00%
This Year
|
Xoma Royalty Corporation
Profile
Xoma Corporation operates under a business model focused on the development and commercialization of novel therapeutics. The company primarily concentrates on creating antibody-based therapies to address unmet medical needs. Xoma also engages in collaborations and partnerships with other pharmaceutical companies to advance their product pipeline and expand their reach in the market.
More about Xoma Royalty Corporation's Market Share
|
An2 Therapeutics Inc
Share Performance
+4.29%
Over The Past 5 Days
|
An2 Therapeutics Inc
Profile
An2 Therapeutics Inc is a biotechnology company that develops therapeutics for the treatment of rare diseases. Their business model focuses on research and development of innovative drugs that target specific genetic mutations responsible for these rare conditions, aiming to provide effective and personalized treatments. By collaborating with pharmaceutical partners and leveraging their expertise in drug discovery, An2 Therapeutics Inc aims to bring their therapies to market and improve the lives of patients with rare diseases.
More about An2 Therapeutics Inc 's Market Share
|
Sigilon Therapeutics Inc
Share Performance
+3.98%
Over The Past 5 Days
|
Sigilon Therapeutics Inc
Profile
Sigilon Therapeutics Inc is a biotechnology company that focuses on developing novel therapies using advanced cell engineering and implantable devices to treat chronic diseases.
More about Sigilon Therapeutics Inc 's Market Share
|
Anaptysbio Inc
Share Performance
+5.02%
Over The Past 5 Days
|
Anaptysbio Inc
Profile
AnaptysBio is a biotechnology company that operates on a partnership-driven business model. They collaborate with pharmaceutical companies to develop and commercialize novel antibody therapeutics using their proprietary antibody discovery technology. By leveraging their expertise in antibody engineering and discovery, AnaptysBio aims to create innovative treatments for a wide range of diseases, including inflammation, immuno-oncology, and rare diseases.
More about Anaptysbio Inc 's Market Share
|
Agios Pharmaceuticals Inc
Share Performance
+5.75%
Over The Past 5 Days
|
Agios Pharmaceuticals Inc
Profile
Agios Pharmaceuticals Inc is a biopharmaceutical company that focuses on researching and developing innovative therapies for treating genetic diseases and cancer.
More about Agios Pharmaceuticals Inc 's Market Share
|
Mirum Pharmaceuticals Inc
Share Performance
+83.83%
One Year
|
Mirum Pharmaceuticals Inc
Profile
Mirum Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing innovative therapies for patients with rare liver diseases.
More about Mirum Pharmaceuticals Inc 's Market Share
|
Puretech Health Plc
Share Performance
-39.33%
One Year
|
Puretech Health Plc
Profile
Puretech Health Plc is a biotechnology company that operates a unique business model focusing on innovation and entrepreneurship. They identify and validate disruptive technologies and build and invest in companies around those technologies, with a focus on identifying unmet medical needs. By developing a diversified portfolio of cutting-edge healthcare companies, Puretech aims to deliver breakthrough therapies to improve patient outcomes.
More about Puretech Health Plc's Market Share
|
Prothena Corporation Public Limited Company
Share Performance
-49.71%
One Year
|
Prothena Corporation Public Limited Company
Profile
Prothena Corporation is a biotechnology company that focuses on developing novel therapies for diseases related to protein misfolding and amyloidosis. Their business model includes leveraging their expertise in antibody and protein engineering to develop and commercialize drug candidates, collaborating with pharmaceutical partners to advance their therapeutic programs, and continuously conducting research and development to expand their pipeline of potential treatments. Their goal is to address unmet medical needs and provide innovative solutions for patients suffering from devastating diseases.
More about Prothena Corporation Public Limited Company's Market Share
|
Bridgebio Pharma Inc
Share Performance
+2.85%
Over The Past 5 Days
|
Bridgebio Pharma Inc
Profile
BridgeBio Pharma Inc is a biopharmaceutical company that focuses on developing and commercializing precision medicines for genetic diseases and cancers. Their business model involves identifying and acquiring early-stage drug candidates, conducting clinical trials, and partnering with other companies for commercialization.
More about Bridgebio Pharma Inc 's Market Share
|
Xenon Pharmaceuticals Inc
Share Performance
-9.48%
30 Days
|
Xenon Pharmaceuticals Inc
Profile
Xenon Pharmaceuticals Inc operates in the biopharmaceutical industry, with a focus on discovering and developing innovative therapeutics. Their business model centers around leveraging their proprietary discovery platform to identify and advance potential drug candidates to address unmet medical needs. Through collaborations, licensing agreements, and internal development efforts, Xenon aims to bring new treatments to patients and create value for their stakeholders.
More about Xenon Pharmaceuticals Inc 's Market Share
|
Structure Therapeutics Inc
Share Performance
+3.90%
Over The Past 5 Days
|
Structure Therapeutics Inc
Profile
Structure Therapeutics Inc is a biotechnology company that utilizes a structure-based approach to develop innovative therapeutics. They focus on identifying and targeting unique protein structures to create novel drugs for various diseases.
More about Structure Therapeutics Inc 's Market Share
|
Prometheus Biosciences Inc
Share Performance
+733.00%
One Year
|
Prometheus Biosciences Inc
Profile
Prometheus Biosciences Inc is a biotechnology company that operates on a subscription-based business model. Their platform offers personalized diagnostic tools and services to healthcare providers, enabling them to deliver targeted treatments for patients with gastrointestinal diseases. By providing ongoing support and monitoring, Prometheus aims to improve patient outcomes and revolutionize the management of chronic conditions in the field of gastroenterology.
More about Prometheus Biosciences Inc 's Market Share
|
Infinity Pharmaceuticals Inc
Share Performance
-96.19%
This Quarter
|
Infinity Pharmaceuticals Inc
Profile
Infinity Pharmaceuticals Inc's business model revolves around the discovery, development, and commercialization of innovative therapies for the treatment of challenging diseases, primarily in the field of oncology.
More about Infinity Pharmaceuticals Inc 's Market Share
|
Nektar Therapeutics
Share Performance
-2.67%
One Year
|
Nektar Therapeutics
Profile
Nektar Therapeutics operates under a business model focused on developing and commercializing innovative medicines. The company's approach involves utilizing its proprietary technology platforms to create novel therapeutic candidates and establish partnerships with pharmaceutical and biotechnology firms for clinical development and commercialization. Nektar Therapeutics aims to bring transformative therapies to market that address significant unmet medical needs.
More about Nektar Therapeutics's Market Share
|
Mannkind Corporation
Share Performance
-4.54%
30 Days
|
Mannkind Corporation
Profile
MannKind Corporation is a biopharmaceutical company that focuses on the development and commercialization of inhaled therapeutic solutions for patients with diseases such as diabetes and pulmonary arterial hypertension. The company's business model revolves around conducting research and development to create innovative inhalation therapies and gaining regulatory approvals for these treatments. They then market and distribute their products, either directly or through partnerships, to healthcare providers and patients worldwide.
More about Mannkind Corporation's Market Share
|
Arvinas Inc
Share Performance
-52.36%
This Year
|
Arvinas Inc
Profile
Arvinas Inc's business model revolves around developing novel therapies based on protein degradation technology to address unmet medical needs.
More about Arvinas Inc 's Market Share
|
Morphosys Ag
Share Performance
+96.68%
This Year
|
Morphosys Ag
Profile
Morphosys Ag's business model revolves around the development and commercialization of therapeutic antibodies.
More about Morphosys Ag's Market Share
|
Puma Biotechnology Inc
Share Performance
+24.00%
This Quarter
|
Puma Biotechnology Inc
Profile
Puma Biotechnology Inc operates as a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for the treatment of cancer. Their business model revolves around identifying promising preclinical and clinical drug candidates, conducting rigorous research and development, and seeking regulatory approval for their products. Puma Biotechnology Inc strives to effectively market and distribute their approved therapeutics to provide patients with potentially life-saving treatment options.
More about Puma Biotechnology Inc 's Market Share
|
Atea Pharmaceuticals Inc
Share Performance
-23.17%
One Year
|
Atea Pharmaceuticals Inc
Profile
Atea Pharmaceuticals Inc. is a biopharmaceutical company that focuses on developing antiviral therapeutics to combat infectious diseases. Their business model revolves around identifying and advancing novel drug candidates that target specific viral mechanisms and inhibit their replication. This includes conducting preclinical and clinical trials, engaging in strategic partnerships, and ultimately bringing effective antiviral treatments to market.
More about Atea Pharmaceuticals Inc 's Market Share
|
Myovant Sciences Ltd
Share Performance
+0.37%
30 Days
|
Myovant Sciences Ltd
Profile
Myovant Sciences Ltd operates under a biopharmaceutical business model primarily focused on the development and commercialization of therapies for women's health and prostate cancer. The company aims to leverage its expertise in clinical research, regulatory affairs, and manufacturing to bring innovative treatments to market and improve patients' lives. Myovant Sciences employs a combination of in-house research and development along with collaboration with strategic partners to advance its pipeline of product candidates.
More about Myovant Sciences Ltd 's Market Share
|
Medicinova Inc
Share Performance
-30.41%
This Quarter
|
Medicinova Inc
Profile
Medicinova Inc operates under a biopharmaceutical business model, primarily focused on the development and commercialization of innovative therapeutics. They strive to identify promising drug candidates with the potential to address unmet medical needs and advance them through clinical trials. By leveraging their research capabilities, strategic partnerships, and licensing opportunities, Medicinova Inc aims to bring these novel treatments to market and improve patient outcomes.
More about Medicinova Inc 's Market Share
|
Xilio Therapeutics Inc
Share Performance
-32.99%
30 Days
|
Xilio Therapeutics Inc
Profile
Xilio Therapeutics Inc is a biotechnology company focused on developing and commercializing novel immunotherapies to treat cancer.
More about Xilio Therapeutics Inc 's Market Share
|
Prelude Therapeutics Inc
Share Performance
-43.35%
This Quarter
|
Prelude Therapeutics Inc
Profile
Prelude Therapeutics Inc is a biopharmaceutical company that focuses on developing innovative small molecule therapeutic products for cancer treatment. Their business model revolves around conducting extensive research and employing a target discovery engine to identify and validate potential drug targets. By using a combination of proprietary technologies and collaborations with academic institutions, Prelude Therapeutics aims to develop and commercialize novel oncology therapies to address unmet medical needs.
More about Prelude Therapeutics Inc's Market Share
|
Eqrx Inc
Share Performance
-6.02%
This Year
|
Eqrx Inc
Profile
Eqrx Inc is a pharmaceutical company that focuses on creating affordable and accessible medication. They employ an innovative business model that combines research and development with scientific expertise to develop generic alternatives to the high-priced drugs in the market. By bypassing the traditional pharmaceutical pricing system, Eqrx aims to make essential medications more affordable for patients and healthcare providers.
More about Eqrx Inc 's Market Share
|
Therapeuticsmd Inc
Share Performance
-17.60%
30 Days
|
Therapeuticsmd Inc
Profile
TherapeuticsMD Inc is a pharmaceutical company that focuses on developing and commercializing innovative hormone therapy products for women. Their business model revolves around research, development, and marketing of prescription and over-the-counter products catering to women's health needs. By leveraging strategic partnerships and collaborations, they aim to bring their products to market, ultimately improving the quality of life for women.
More about Therapeuticsmd Inc's Market Share
|
Legend Biotech Corporation
Share Performance
-2.66%
30 Days
|
Legend Biotech Corporation
Profile
Legend Biotech Corporation is a biotech company focused on developing innovative cell therapies and gene therapies to address unmet medical needs in various diseases.
More about Legend Biotech Corporation's Market Share
|
Beigene Ltd
Share Performance
+3.85%
One Year
|
Beigene Ltd
Profile
BeiGene Ltd is a biotechnology company that focuses on discovering, developing, and commercializing innovative medicines to meet the needs of cancer patients in China and worldwide. They follow a vertically integrated business model, with expertise in research and development, manufacturing, and commercialization, allowing them to have control over the entire drug development process. By leveraging strategic partnerships and collaborations, BeiGene aims to bring forth cutting-edge therapies and improve treatment options for cancer patients.
More about Beigene Ltd 's Market Share
|
Organon and Co
Share Performance
-14.75%
One Year
|
Organon and Co
Profile
Organon and Co's business model revolves around developing and manufacturing pharmaceutical products.
More about Organon and Co 's Market Share
|
Teva Pharmaceutical Industries Limited
Share Performance
-23.76%
This Year
|
Teva Pharmaceutical Industries Limited
Profile
Teva Pharmaceutical Industries Limited is a multinational pharmaceutical company that focuses on the development, production, and marketing of generic and specialty medicines. They aim to provide affordable and accessible healthcare solutions to patients worldwide.
More about Teva Pharmaceutical Industries Limited's Market Share
|
Viatris Inc
Share Performance
-13.00%
30 Days
|
Viatris Inc
Profile
Viatris Inc operates as a global pharmaceutical company, specializing in the development, manufacturing, and distribution of a wide range of generic and branded medicines, as well as biosimilars.
More about Viatris Inc 's Market Share
|
Astrazeneca Plc
Share Performance
+17.09%
This Quarter
|
Astrazeneca Plc
Profile
AstraZeneca Plc is a global biopharmaceutical company focused on the research, development, and commercialization of innovative medicines. Their business model involves investing extensively in research and development to discover novel treatments for a wide range of diseases. AstraZeneca then markets and sells these medicines globally, collaborating with healthcare providers and leveraging their strong sales and distribution networks.
More about Astrazeneca Plc's Market Share
|
Allarity Therapeutics Inc
Share Performance
-3.03%
This Quarter
|
Allarity Therapeutics Inc
Profile
Allarity Therapeutics Inc is a biotechnology company that leverages its unique drug response profiling platform to develop personalized cancer treatments. They use AI algorithms to match patients with the most effective therapies by analyzing their individual molecular profiles.
More about Allarity Therapeutics Inc 's Market Share
|
Viracta Therapeutics Inc
Share Performance
-97.66%
One Year
|
Viracta Therapeutics Inc
Profile
Viracta Therapeutics Inc is a biopharmaceutical company focused on developing targeted therapies for viral-associated cancers. The company aims to advance research, develop innovative treatments, and commercialize products to improve the lives of patients suffering from these types of cancers.
More about Viracta Therapeutics Inc 's Market Share
|
Biophytis Sa
Share Performance
-92.84%
One Year
|
Biophytis Sa
Profile
Biophytis SA is a biotechnology company that focuses on developing innovative therapeutics for age-related diseases, with a specific emphasis on degenerative eye diseases and muscle wasting conditions. They leverage their expertise in biology and clinical development to discover and advance targeted drug candidates, aiming to address the unmet medical needs of patients in these areas.
More about Biophytis Sa's Market Share
|
Nanoviricides inc
Share Performance
-11.41%
This Quarter
|
Nanoviricides inc
Profile
Nanoviricides Inc. is a pharmaceutical company that operates on a business model based on the development and commercialization of nanomedicines.
More about Nanoviricides inc 's Market Share
|
Immuron Limited
Share Performance
+1.93%
This Year
|
Immuron Limited
Profile
Immuron Limited's business model involves the development and commercialization of oral immunotherapeutics that target and treat various diseases.
More about Immuron Limited's Market Share
|
Iterum Therapeutics Plc
Share Performance
-18.08%
This Quarter
|
Iterum Therapeutics Plc
Profile
Iterum Therapeutics Plc is a pharmaceutical company that focuses on the research, development, and commercialization of innovative anti-infectives for the treatment of serious and life-threatening infections. They aim to address unmet medical needs in this space by advancing their product candidates through clinical trials and ultimately bringing them to market.
More about Iterum Therapeutics Plc's Market Share
|
Esperion Therapeutics inc
Share Performance
+8.00%
Over The Past 5 Days
|
Esperion Therapeutics inc
Profile
Esperion Therapeutics Inc's business model focuses on the development and commercialization of innovative therapies for addressing cardiovascular diseases.
More about Esperion Therapeutics inc 's Market Share
|
Cellectar Biosciences inc
Share Performance
+65.26%
This Quarter
|
Cellectar Biosciences inc
Profile
Cellectar Biosciences Inc is a biopharmaceutical company that focuses on the development of targeted cancer therapies. They utilize their proprietary drug conjugation platform to create targeted small molecules that can selectively bind and deliver radioactive isotopes directly to cancer cells. Their business model revolves around developing and commercializing these innovative therapies for the treatment of various types of cancer, aiming to improve patient outcomes and potentially revolutionize cancer treatment.
More about Cellectar Biosciences inc 's Market Share
|
Journey Medical Corp
Share Performance
+6.10%
Over The Past 5 Days
|
Journey Medical Corp
Profile
Journey Medical Corporation is a pharmaceutical and medical device company that specializes in developing and commercializing innovative products for dermatology and aesthetics. Their business model revolves around conducting research and development to create new products, acquiring the necessary regulatory approvals, and partnering with healthcare professionals to effectively distribute and market these products. By focusing on dermatology and aesthetics, Journey Medical Corporation aims to address unmet medical needs and provide cutting-edge solutions to improve patient outcomes in these fields.
More about Journey Medical Corp's Market Share
|
Casi Pharmaceuticals inc
Share Performance
-13.21%
This Quarter
|
Casi Pharmaceuticals inc
Profile
Casi Pharmaceuticals Inc. operates under a business model that focuses on the development and commercialization of innovative pharmaceutical products. They likely employ a combination of in-house research and development, partnerships, and licensing agreements to bring their products to market. The company may also engage in strategic marketing and distribution partnerships to ensure the successful commercialization of their therapeutics.
More about Casi Pharmaceuticals inc 's Market Share
|
Mineralys Therapeutics Inc
Share Performance
+17.40%
Over The Past 5 Days
|
Mineralys Therapeutics Inc
Profile
Mineralys Therapeutics Inc is a biotechnology company that follows the business model of developing and commercializing novel therapeutics for various diseases. They focus on discovering and advancing small molecule drugs based on innovative research approaches. Their business model is centered around conducting preclinical and clinical trials, obtaining regulatory approvals, and ultimately bringing their therapeutic products to market for improved patient outcomes.
More about Mineralys Therapeutics Inc 's Market Share
|
Mirati Therapeutics Inc
Share Performance
+3.77%
This Quarter
|
Mirati Therapeutics Inc
Profile
Mirati Therapeutics Inc is a biotechnology company that focuses on the research, discovery, and development of precision oncology treatments for patients with cancer. Their business model involves leveraging their proprietary drug discovery platform to identify and develop targeted therapies, and collaborating with partners for the commercialization of their products.
More about Mirati Therapeutics Inc 's Market Share
|
Johnson and Johnson
Share Performance
+12.84%
This Quarter
|
Johnson and Johnson
Profile
Johnson & Johnson operates as a multinational healthcare company with a diversified business model that spans pharmaceuticals, medical devices, and consumer health products. By focusing on innovation and strategic acquisitions, the company aims to improve global health and well-being.
More about Johnson and Johnson's Market Share
|
Merck and Co Inc
Share Performance
-4.48%
This Year
|
Merck and Co Inc
Profile
Merck & Co. Inc. operates primarily as a research-driven pharmaceutical company, focused on the development, manufacturing, and marketing of prescription drugs and vaccines globally. It aims to address unmet medical needs through innovative research, collaborations, and rigorous clinical trials, while promoting patient well-being and contributing to global healthcare with high-quality, affordable medications.
More about Merck and Co Inc 's Market Share
|
Bristol myers Squibb Company
Share Performance
+9.89%
30 Days
|
Bristol myers Squibb Company
Profile
Bristol Myers Squibb Company operates a research and development-driven business model, focusing on the discovery and delivery of innovative medicines for various diseases. It emphasizes collaboration with academic institutions, government entities, and other pharmaceutical firms to enhance its therapeutic portfolio and improve patient outcomes.
More about Bristol myers Squibb Company's Market Share
|
Sources: Astria Therapeutics inc and all companies mentioned above in this report
|
